Published in Sex Transm Dis on March 01, 2006
Relative efficacy of a multisession sexual risk-reduction intervention for young men released from prisons in 4 states. Am J Public Health (2006) 1.86
Associations of sex ratios and male incarceration rates with multiple opposite-sex partners: potential social determinants of HIV/STI transmission. Public Health Rep (2010) 1.79
Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. J Acquir Immune Defic Syndr (2010) 1.62
HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners. Am J Drug Alcohol Abuse (2010) 1.48
A longitudinal study of incarceration and HIV risk among methadone maintained men and their primary female partners. AIDS Behav (2011) 1.40
Incarceration, African Americans and HIV: advancing a research agenda. J Natl Med Assoc (2008) 1.38
Moving upstream: ecosocial and psychosocial correlates of sexually transmitted infections among young adults in the United States. Am J Public Health (2008) 1.33
Examining the temporal relationship between criminal justice involvement and sexual risk behaviors among drug-involved men. J Urban Health (2010) 1.13
Rapid HIV testing for individuals on probation/parole: outcomes of an intervention trial. AIDS Behav (2013) 1.10
History of arrest and associated factors among men who have sex with men. J Urban Health (2011) 1.02
HIV testing and treatment with correctional populations: people, not prisoners. J Health Care Poor Underserved (2010) 1.00
The relationship between housing status and HIV risk among active drug users: a qualitative analysis. Subst Use Misuse (2009) 0.99
The high prevalence of incarceration history among Black men who have sex with men in the United States: associations and implications. Am J Public Health (2014) 0.95
Linkage to care for HIV-infected heterosexual men in the United States. Clin Infect Dis (2011) 0.95
Neighborhood context and Black heterosexual men's sexual HIV risk behaviors. AIDS Behav (2014) 0.92
STI/HIV Sexual Risk Behavior and Prevalent STI Among Incarcerated African American Men in Committed Partnerships: The Significance of Poverty, Mood Disorders, and Substance Use. AIDS Behav (2015) 0.90
Improving healthcare for incarcerated women. J Womens Health (Larchmt) (2010) 0.84
Access to housing subsidies, housing status, drug use and HIV risk among low-income U.S. urban residents. Subst Abuse Treat Prev Policy (2011) 0.84
Economic, Legal, and Social Hardships Associated with HIV Risk among Black Men who have Sex with Men in Six US Cities. J Urban Health (2016) 0.79
Black Americans and Incarceration: A Neglected Public Health Opportunity for HIV Risk Reduction. J Health Care Poor Underserved (2016) 0.75
Can drug users be effective change agents? Yes, but much still needs to change. Subst Use Misuse (2010) 0.75
Lessons learned from use of highly active antiretroviral therapy in Africa. Clin Infect Dis (2005) 4.96
Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis (2002) 3.27
Feasibility and acceptability of rapid HIV testing in jail. AIDS Patient Care STDS (2007) 2.52
It is time to implement routine, not risk-based, HIV testing. Clin Infect Dis (2005) 2.40
Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis (2002) 2.39
Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. J Acquir Immune Defic Syndr (2006) 2.30
Predictors of risky sex of young men after release from prison. Int J STD AIDS (2003) 2.11
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr (2011) 1.97
Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India. J Acquir Immune Defic Syndr (2004) 1.97
The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India. Clin Infect Dis (2005) 1.95
The importance of routine HIV testing in the incarcerated population: the Rhode Island experience. AIDS Educ Prev (2002) 1.91
A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS (2007) 1.83
Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved (2008) 1.81
Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol (2002) 1.76
Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis (2006) 1.72
Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr (2002) 1.71
Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world. AIDS (2011) 1.63
"You cannot do nothing in this damn place": sex and intimacy among couples with an incarcerated male partner. J Sex Res (2005) 1.59
Adverse effects of highly active antiretroviral therapy in developing countries. Clin Infect Dis (2007) 1.56
HIV and STD risk behavior among 18- to 25-year-old men released from U.S. prisons: provider perspectives. AIDS Behav (2003) 1.50
The carceral limb of the public body: jail inmates, prisoners, and infectious disease. J Int Assoc Physicians AIDS Care (Chic) (2004) 1.48
Bathhouse-based voluntary counseling and testing is feasible and shows preliminary evidence of effectiveness. J Acquir Immune Defic Syndr (2006) 1.47
The use of community-based modified directly observed therapy for the treatment of HIV-infected persons. J Acquir Immune Defic Syndr (2005) 1.46
Clinical profile of HIV in India. Indian J Med Res (2005) 1.41
The efficacy of female condom skills training in HIV risk reduction among women: a randomized controlled trial. Am J Public Health (2008) 1.40
A diagnostic dilemma in a patient receiving antiretroviral and antituberculosis therapy. AIDS Read (2005) 1.38
Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy. AIDS (2007) 1.34
HIV, STD, and hepatitis risk behaviors of young men before and after incarceration. AIDS Care (2009) 1.33
Adherence to HIV treatment and care among previously homeless jail detainees. AIDS Behav (2013) 1.33
HIV and STD testing in prisons: perspectives of in-prison service providers. AIDS Educ Prev (2003) 1.31
Apathy is associated with volume of the nucleus accumbens in patients infected with HIV. J Neuropsychiatry Clin Neurosci (2005) 1.29
The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India. AIDS (2003) 1.27
A success story: HIV prevention for injection drug users in Rhode Island. Subst Abuse Treat Prev Policy (2006) 1.26
A longitudinal, qualitative analysis of the context of substance use and sexual behavior among 18- to 29-year-old men after their release from prison. Soc Sci Med (2007) 1.26
Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients. AIDS Patient Care STDS (2008) 1.26
The impact of apathy and depression on quality of life in patients infected with HIV. AIDS Patient Care STDS (2003) 1.24
Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus. J Neuropsychiatry Clin Neurosci (2005) 1.18
Rapid vs. standard HIV testing in bathhouses: what is gained and lost? AIDS Behav (2008) 1.17
Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings. J Acquir Immune Defic Syndr (2004) 1.13
Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative. J Acquir Immune Defic Syndr (2011) 1.10
Patterns and predictors of female condom use among ethnically diverse women attending family planning clinics. Sex Transm Dis (2003) 1.08
HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis (2013) 1.07
Whole-body positron emission tomography in patients with HIV-1 infection. Lancet (2003) 1.07
Building stakeholder partnerships for an on-site HIV testing programme. Cult Health Sex (2008) 1.06
A review of the case for hepatitis B vaccination of high-risk adults. Am J Med (2003) 1.06
Making sure research is used: community-generated recommendations for disseminating research. Prog Community Health Partnersh (2008) 1.05
Acceptability of sexually transmitted infection screening among women in short-term substance abuse treatment. Sex Transm Dis (2002) 1.04
A qualitative study of substance use and sexual behavior among 18- to 29-year-old men while incarcerated in the United States. Health Educ Behav (2004) 1.03
Initial outcomes of an emergency department rapid HIV testing program in western Kenya. AIDS Patient Care STDS (2007) 1.03
Substance use and sexual behavior during incarceration among 18- to 29-year old men: prevalence and correlates. AIDS Behav (2007) 1.02
Screening for sexually transmitted diseases and hepatitis in 18-29-year-old men recently released from prison: feasibility and acceptability. Int J STD AIDS (2005) 1.02
Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS Behav (2013) 1.02
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine. J Acquir Immune Defic Syndr (2011) 1.02
HIV testing and treatment with correctional populations: people, not prisoners. J Health Care Poor Underserved (2010) 1.00
Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings. Am J Public Health (2014) 0.99
HIV screening in the health care setting: status, barriers, and potential solutions. Mayo Clin Proc (2012) 0.98
Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1. Clin Infect Dis (2002) 0.97
Young incarcerated men's perceptions of and experiences with HIV testing. Am J Public Health (2007) 0.97
Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients. AIDS (2005) 0.95
HIV-positive and in jail: race, risk factors, and prior access to care. AIDS Behav (2013) 0.95
Lessons learned from family-centred models of treatment for children living with HIV: current approaches and future directions. J Int AIDS Soc (2010) 0.95
Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care. J Acquir Immune Defic Syndr (2011) 0.94
Lipid changes in patients initiating efavirenz- and indinavir-based antiretroviral regimens. HIV Clin Trials (2003) 0.91
Planning for success predicts virus suppressed: results of a non-controlled, observational study of factors associated with viral suppression among HIV-positive persons following jail release. AIDS Behav (2013) 0.91
Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India. PLoS One (2013) 0.91
Newly identified HIV infections in correctional facilities, United States, 2007. Am J Public Health (2012) 0.89
Routine HIV testing among inpatients. Arch Intern Med (2002) 0.89
HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients. AIDS (2002) 0.89
HIV risk behavior before and after HIV counseling and testing in jail: a pilot study. J Acquir Immune Defic Syndr (2010) 0.88
Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2005) 0.87
Safety, Tolerability, and Efficacy of Second-Line Generic Protease Inhibitor Containing HAART after First-Line Failure among South Indian HIV-Infected Patients. J Int Assoc Physicians AIDS Care (Chic) (2011) 0.85
Short communication: new HIV infections at Southern New England academic institutions: implications for prevention. AIDS Res Hum Retroviruses (2012) 0.84
Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India. PLoS One (2010) 0.84
The intertwined epidemics of HIV infection, incarceration, and substance abuse: a call to action. J Infect Dis (2011) 0.83
Changes in demographics and risk factors among persons living with HIV in an academic medical center from 2003-2007. Med Health R I (2009) 0.83
Racial/ethnic attitudes towards HIV testing in the primary care setting. J Natl Med Assoc (2005) 0.82
Follow-up care among HIV-infected pregnant women in Mississippi. J Womens Health (Larchmt) (2010) 0.82
Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen. Clin Infect Dis (2011) 0.81
Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy? J Addict Med (2012) 0.81
Monitoring HIV treatment in the developing world. Lancet Infect Dis (2002) 0.80
HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City. AIDS Res Treat (2011) 0.80
Community-based interventions for marginalized populations. Clin Infect Dis (2004) 0.80
Small reservoirs: jail screening for gonorrhea and Chlamydia in low prevalence areas. J Correct Health Care (2009) 0.79
Directly observed therapy (DOT) for individuals with HIV: successes and challenges. MedGenMed (2003) 0.79
HIV among marginalized populations in Rhode Island. Med Health R I (2009) 0.79
Advance directives among people living with HIV: room for improvement. AIDS Care (2014) 0.79
Routine HIV testing in jails is critical for the early diagnosis of HIV infection in men. Clin Infect Dis (2008) 0.78
Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients. AIDS Patient Care STDS (2004) 0.78
Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence. AIDS (2003) 0.78
Clinical outcomes among HIV/tuberculosis-coinfected patients developing immune reconstitution inflammatory syndrome after HAART initiation in South India. J Int Assoc Provid AIDS Care (2012) 0.78
Editorial commentary: Hepatitis C virus testing and drug use in north america; is there more than meets the eye? Clin Infect Dis (2013) 0.77
The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult. Clin Infect Dis (2006) 0.77
Directly observed therapy for HIV/tuberculosis co-infection. Lancet Infect Dis (2004) 0.76
Responsibility for HIV prevention: patterns of attribution among HIV-seropositive gay and bisexual men. AIDS Educ Prev (2007) 0.76
Routine HIV testing in US prisons. Lancet Infect Dis (2007) 0.76
Risk factors for non-communicable diseases in prison populations. Lancet (2012) 0.75
HIV counseling and testing among injection drug users needs to continue. Am J Public Health (2007) 0.75
Screening for HIV. Ann Intern Med (2005) 0.75
HIV testing practices among New England college health centers. AIDS Res Ther (2013) 0.75